Group | FPHT | LEV | P value |
n | 80 | 93 | |
Primary outcome | |||
Seizure cessation within 30 min, n (%) | 67 (83.8) | 83 (89.2) | 0.29 |
Secondary outcome | |||
Seizure recurrence rate within 24 hours, n (%) | 12 (15.0) | 16 (17.2) | 0.70 |
Intubation within 24 hours, (%) | 12 (15.0) | 15 (16.1) | 0.84 |
Other outcomes | |||
Modified Rankin Scale 7 days after admission | 0.74 | ||
0 (no symptoms) | 21 (26.3) | 26 (28.0) | |
1 (no significant disability) | 16 (20.0) | 13 (14.0) | |
2 (slight disability) | 8 (10.0) | 6 (6.5) | |
3 (moderate disability) | 7 (8.8) | 8 (8.6) | |
4 (moderately severe disability) | 14 (17.5) | 18 (19.4) | |
5 (severe disability) | 11 (13.8) | 20 (21.5) | |
6 (dead) | 3 (3.8) | 2 (2.2) |
Each variable is expressed as n (%) and compared using the χ2 test.
FPHT, fosphenytoin; LEV, levetiracetam.